panobinostat and Tumor-Lysis-Syndrome

panobinostat has been researched along with Tumor-Lysis-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for panobinostat and Tumor-Lysis-Syndrome

Article	Year
Laboratory tumor lysis syndrome complicating LBH589 therapy in a patient with acute myeloid leukaemia. Haematologica, 2008, Volume: 93, Issue:1 LBH589 is a novel cinnamic hydroxamic acid analog (HAA) pan-histone deacetylase inhibitor (HDACi) currently in early phase clinical development. Topics: Disease Progression; Electrolytes; Enzyme Inhibitors; Fatal Outcome; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Leukemia, Myeloid, Acute; Male; Middle Aged; Panobinostat; Tumor Lysis Syndrome	2008

Article

Year

Laboratory tumor lysis syndrome complicating LBH589 therapy in a patient with acute myeloid leukaemia.

Haematologica, 2008, Volume: 93, Issue:1

LBH589 is a novel cinnamic hydroxamic acid analog (HAA) pan-histone deacetylase inhibitor (HDACi) currently in early phase clinical development.

Topics: Disease Progression; Electrolytes; Enzyme Inhibitors; Fatal Outcome; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Leukemia, Myeloid, Acute; Male; Middle Aged; Panobinostat; Tumor Lysis Syndrome

2008